Katerina Ajami
- Oncology top 10%
- Cellular and Molecular Neuroscience top 10%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 10%
- Cancer Research
- Co-authors
- Mark D. GorrellGeoffrey W. McCaughanCatherine A. AbbottJoohong ParkMelissa R. PitmanXin WangDenise YuNicholas Shackel
- Topics
- Peptidase Inhibition and Analysis (10 papers)Neuropeptides and Animal Physiology (8 papers)Diabetes Treatment and Management (5 papers)
- Partner nations
- AustraliaUnited StatesCanada
In The Last Decade
Katerina Ajami
12 papers receiving 500 citations
Peers
Comparison fields: 5 of 49
- Oncology 401
- Cellular and Molecular Neuroscience 245
- Molecular Biology 182
- Endocrinology, Diabetes and Metabolism 134
- Cancer Research 113
Countries citing papers authored by Katerina Ajami
This map shows the geographic impact of Katerina Ajami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katerina Ajami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katerina Ajami more than expected).
Fields of papers citing papers by Katerina Ajami
This network shows the impact of papers produced by Katerina Ajami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katerina Ajami. The network helps show where Katerina Ajami may publish in the future.
Co-authorship network of co-authors of Katerina Ajami
This figure shows the co-authorship network connecting the top 25 collaborators of Katerina Ajami. A scholar is included among the top collaborators of Katerina Ajami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katerina Ajami. Katerina Ajami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 35 | |
| 3 | 27 | |
| 4 | 72 | |
| 5 | 71 | |
| 6 | 22 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 19 | |
| 10 | 19 | |
| 11 | 113 | |
| 12 | 62 |
About Katerina Ajami
Katerina Ajami is a scholar working on Cellular and Molecular Neuroscience, Oncology and Immunology and Allergy, having authored 12 papers that have together received 509 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (8 papers) and Diabetes Treatment and Management (5 papers). The work is most often cited by research in Oncology (401 citations), Cellular and Molecular Neuroscience (245 citations) and Endocrinology, Diabetes and Metabolism (134 citations). Katerina Ajami has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Mark D. Gorrell, Geoffrey W. McCaughan, Catherine A. Abbott, Joohong Park, Melissa R. Pitman, Xin Wang, Denise Yu, Nicholas Shackel, Vanessa Gysbers and Thilo Kähne. Their work appears in journals such as Biochemistry, FEBS Letters and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.